iRhythm Technologies IncChange company Symbol lookupSelect an option...IRTC iRhythm Technologies IncHBI HanesBrands IncTMKR Tastemaker Acquisition CorpSPY SPDR® S&P 500 ETF TrustSTOR STORE Capital CorpPIPP^ Pine Island Acquisition CorpPEP PepsiCo Inc$NASI5000LMN NASDAQ Asia Cnsmr Svcs Large Mid CapPNM PNM Resources IncCBLAQ CBL & Associates Properties IncGo
iRhythm Technologies, Inc. is a digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its ZIO Report produces a higher diagnostic yield and to change patient management. The Company’s Zio service combines a wire-free, patch-based, wearable biosensor with a proprietary cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.
|
|
|
|
| |
Company Profile
iRhythm Technologies, Inc. is a digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its ZIO Report produces a higher diagnostic yield and to change patient management. The Company’s Zio service combines a wire-free, patch-based, wearable biosensor with a proprietary cloud-based data analytic platform to help physicians monitor patients and diagnose arrhythmias.
Valuation Ratios
- Price/Earnings (TTM)
- --
- Price/Sales (TTM)
- 15.26x
- Price/Book (MRQ)
- 11.79x
- Price/Cash Flow (TTM)
- --
MRQ = Most Recent Quarter
Price Performance
Financial Statements
Balance sheet
Values displayed are in millions.
Income statement
Values displayed are in thousands.
Cash flow
Values displayed are in thousands.
Company Officers
- Abhijit Y. TalwalkarChmn.
- Michael J. CoylePres.
- Douglas DevineCFO
- David A. VortExec.VP
- Mark J. DayExec.VP
Address
- 650 Townsend St Ste 500
- San Francisco, CA 94103-6227
- Phone: (415) 632-5700
- Fax: (302) 655-5049
- https://www.irhythmtech.com/
Insider Trading
During the most recent quarter, 115K shares were sold in insider trading.
Insider trading information report provided by Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.